Viking Therapeutics (VKTX) Misses Q2 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• GE Aerospace to acquire Consolidated Precision in $11.75b deal
• Activist investor presses Xerox to review financial services arm - Bloomberg